HomeOpen Access NewsDrug Development

Drug Development

First-ever NHS treatment approved for advanced Hodgkin lymphoma

New combination therapy will be available on the NHS, offering new hope to people with advanced Hodgkin lymphoma.

What are the mental and physical health benefits of essential oils?

Essential oils have been used for centuries for their medicinal properties. However, scientists have only now started studying and exploring the potential benefits of essential oils.

Type 1 diabetes treatment finds new target

A new route to the regeneration of insulin in the pancreatic stem cells indicates a major breakthrough for Types 1 and 2 Diabetes therapies.

Acoustic Cluster Therapy – A novel ultrasound-mediated drug delivery platform for therapeutic enhancement across multiple diseases

Optimising a drug’s ability to reach diseased body parts in adequate levels while avoiding healthy body parts – its tissue exposure and selectivity – is critical to therapeutic optimisation.

Beating lung cancer with the AI edge

Prashant Warier, CEO and Founder, Qure.ai, explains beating lung cancer with the AI edge.

UK Cannabis Industry – the next Scottish Whisky

Nick Morland, Tenacious Labs CEO, All-Party Parliamentary Group for CBD Products Secretariat, Jersey Cannabis Services Advisory Board Chair, writes about the UK Cannabis Industry – could this be the next Scottish Whisky?

Thailand gives out one million free cannabis plants to promote legalisation

One million homes will be given cannabis plants across Thailand, to mark the legalisation and attract foreign tourists – to be used for ‘medicinal purposes’ only.

NIH begins clinical trial for Epstein-Barr virus vaccine

The clinical trial will test an Epstein-Barr virus vaccine developed by Novavax, one of just two attempts in over a decade.

Study explores cheaper way to produce compounds for pharmaceuticals

Researchers have developed a new tool that can make it easier and cheaper to fabricate the compounds needed for pharmaceuticals.

Ukrainian patients lose access to multiple sclerosis drug trial

Biotechnology giant Roche warns that multiple sclerosis (MS) drug trials are compromised in Ukraine - with patients losing access to crucial treatment.

Can people alleviate depression with psilocybin microdosing?

Psychedelic use has been found to have positive effects on mental disorders – now, psilocybin microdosing shows hope for relieving depression.

Powerful new COVID treatment cuts hospital deaths by 55%

So far, there is no treatment for severe cases - but now, clinical trials for a new COVID treatment show immense promise in preventing death.

Diabetes – Is life without insulin possible?

Imagine a life without insulin: Research is bringing us closer to a cure and could change the lives of diabetes patients

Scientists create non-hormonal male birth control 

Scientists made progress on the implementation of male birth control, which could someday split contraceptive responsibility between all genders.

Next-generation digital tools for mobility in research & health

Beatrix Vereijken and Lynn Rochester share how Mobilise-D develops digital technology to measure mobility in daily life to transform clinical research and health.

Finding innovative ways to deal with bacteria

Professor of Evolutionary Biology Ashleigh S. Griffin discusses harnessing the power of evolutionary process instead of fighting it, particularly regarding bacterial cells and cooperation.

Drug with the ability to reprogramme aggressive brain tumours 

Study shows L-methylfolate, when administered alongside standard therapy for glioblastomas, changed the DNA process within a patients tumour

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders